ASAP3 and hepatocellular carcinoma: Our future studies will generate human hepatocyte organoids from patients with high and low ACAP4 levels and test whether celastrol exhibits any selectivity in the context of ACAP4 activity and identify if there are additional effectors downstream from ROCK2 in HCC cell migration.